curon medical –

Sunnyvale, Calif.

Went public 9/22/2000 at $11 per share

Filing Range: 5.0 mil. shares @ $11 to $13

Shares Outstanding: 18.7 mil. shares

Underwriters: UBS Warburg/CIBC World Markets/SG Cowen

Securities Corp.

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Dewey Ballantine LLP

Auditor: Pricewaterhouse Coopers LLP

The Company:

Develops medical instruments and devices for endoscopic treatment of Gastroesophageal Reflux Disease (GERD). The products consist of radiofrequency generators and single-use disposable devices.

Venture Backers:

Onset Ventures

U.S. Venture Partners

U.S. Trust Private Equity

Travelers Insurance Co.

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 06/01/1998 1 Early Stage 1866.0

2 12/10/1998 4 Expansion 5794.0

3 08/25/1999 5 Later Stage 17741.0

4 05/19/2000 4 Later Stage 11090.0

Financials:

(Data in $ millions)

Y/E

12/31/99

Total Revenues: $0.0

Net Income: -14.1